Literature DB >> 8921363

Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS.

P Aman1, I Panagopoulos, C Lassen, T Fioretos, M Mencinger, H Toresson, M Höglund, A Forster, T H Rabbitts, D Ron, N Mandahl, F Mitelman.   

Abstract

FUS (TLS) was first identified as the 5'-part of a fusion gene with CHOP (GADD153, DDIT3) in myxoid liposarcomas with t(12; 16)(q13; p11). Homologies were found with the EWS oncogene, which is rearranged in Ewing sarcomas and other neoplasias. The genomic structure of FUS shows extensive similarities with that of EWS, but the exon/intron structures differ in the 5' parts, and overall FUS is smaller than EWS. Exon 3 of FUS corresponds to exons 3 and 4 in EWS. FUS exons 4-6 correspond to EWS exons 5-8. Exons 7 to 15 of FUS are very similar to those in EWS, although the EWS exons are larger than the corresponding FUS exons. FUS and EWS were expressed in all tissues investigated. The transcripts were stable within the 160-min half-life experiments. No or little variation in FUS or EWS expression was seen when resting lymphocytes were activated. These observations indicate that FUS and EWS belong to the housekeeping type of genes. This view is supported by the presence of the housekeeping gene type of promoter region in both genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921363     DOI: 10.1006/geno.1996.0513

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  47 in total

1.  Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).

Authors:  H Ichikawa; K Shimizu; R Katsu; M Ohki
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Induction of a secreted protein by the myxoid liposarcoma oncogene.

Authors:  M Kuroda; X Wang; J Sok; Y Yin; P Chung; J W Giannotti; K A Jacobs; L J Fitz; P Murtha-Riel; K J Turner; D Ron
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 3.  Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.

Authors:  Stephen L Lessnick; Marc Ladanyi
Journal:  Annu Rev Pathol       Date:  2011-09-19       Impact factor: 23.472

4.  Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence.

Authors:  Joonseok Cho; Hongmei Shen; Hui Yu; Hongjie Li; Tao Cheng; Sean Bong Lee; Byeong Chel Lee
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

5.  In vitro interaction between the N-terminus of the Ewing's sarcoma protein and the subunit of RNA polymerase II hsRPB7.

Authors:  Roumiana Todorova
Journal:  Mol Biol Rep       Date:  2008-07-08       Impact factor: 2.316

6.  Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease.

Authors:  Manuela Neumann; Sigrun Roeber; Hans A Kretzschmar; Rosa Rademakers; Matt Baker; Ian R A Mackenzie
Journal:  Acta Neuropathol       Date:  2009-08-09       Impact factor: 17.088

Review 7.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

Review 8.  Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors.

Authors:  Khin Thway; Andrew L Folpe
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

Review 9.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

10.  Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.

Authors:  S-M Oh; Z Liu; M Okada; S-W Jang; X Liu; C-B Chan; H Luo; K Ye
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.